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Constitutive expression of stromal derived factor-1 by mucosal
epithelia and its role in HIV transmission and propagation
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HIV particles that use the chemokine receptor CXCR4
as a coreceptor for entry into cells (X4-HIV) inefficiently
transmit infection across mucosal surfaces [1], despite
their presence in seminal fluid and mucosal secretions
from infected individuals [2–4]. In addition, although
intestinal lymphocytes are susceptible to infection with
either X4-HIV particles or particles that use the
chemokine receptor CCR5 for viral entry (R5-HIV) during
ex vivo culture [5], only systemic inoculation of
R5-chimeric simian-HIV (S-HIV) results in a rapid loss of
CD4+ intestinal lymphocytes in macaques [6]. The
mechanisms underlying the inefficient capacity of
X4-HIV to transmit infection across mucosal surfaces
and to infect intestinal lymphocytes in vivo have
remained elusive. The CCR5 ligands RANTES, MIP-1α
and MIP-1β suppress infection by R5-HIV-1 particles via
induction of CCR5 internalization, and individuals
whose peripheral blood lymphocytes produce high
levels of these chemokines are relatively resistant to
infection [7–9]. Here, we show that the CXCR4 ligand
stromal derived factor-1 (SDF-1) is constitutively
expressed by mucosal epithelial cells at sites of HIV
transmission and propagation. Furthermore, CXCR4 is
selectively downmodulated on intestinal lymphocytes
within the setting of prominent SDF-1 expression. We
postulate that mucosally derived SDF-1 continuously
downmodulates CXCR4 on resident HIV target cells,
thereby reducing the transmission and propagation of
X4-HIV at mucosal sites. Moreover, such a mechanism
could contribute to the delayed emergence of X4
isolates, which predominantly occurs during the later
stages of the HIV infection.
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Results and discussion
We hypothesized that the inefficient capacity of X4-HIV
to transmit infection across mucosal surfaces and to propa-
gate within intestinal lymphocytes might be due to SDF-1
expression at mucosal surfaces. We therefore determined
whether SDF-1 was present within mucosal sites.
Immunohistochemical analysis with the recently described
monoclonal anti-SDF-1 antibody K15C [10] showed strong
staining of human intestinal epithelial cells (Figure 1a). In
addition, there were brightly stained cells scattered within
the lamina propria and submucosa (Figure 1a, arrows). In
contrast, no staining was observed with an isotype-
matched control monoclonal antibody (Figure 1a). To
determine the site of SDF-1 production within normal
intestinal tissues, in situ hybridization was performed. In
this analysis, SDF-1 mRNA was constitutively expressed
by epithelial cells within the normal small intestine
(Figure 1a) and large intestine (data not shown). As with
immunostaining, strong SDF-1 mRNA expression was
detected in scattered cells in the lamina propria and sub-
mucosa (Figure 1a, arrows). In contrast, no hybridization
was observed in intestinal tissue sections hybridized with
the control SDF-1 sense riboprobe (Figure 1a).
Immunohistochemical analysis also detected prominent
SDF-1 expression in columnar epithelial cells within the
rectum and endocervix and the basal epithelial layers
within the vagina and ectocervix (Figure 1b, top panel),
but no staining was observed with an isotype-matched
control antibody (see Supplementary material). In all of
these sites, anti-SDF-1 staining was blocked by the addi-
tion of SDF-1α (Figure 1b, bottom panel), demonstrating
that the antigen-binding region of this monoclonal anti-
body was critical for its immunoreactivity. Thus, promi-
nent SDF-1 expression occurs at mucosal tissues that are
highly relevant for HIV transmission and propagation.
To determine whether prominent SDF-1 expression at
mucosal surfaces might influence expression of the
X4-HIV co-receptor and SDF-1 ligand CXCR4, we exam-
ined CXCR4 expression on intestinal lymphocyte popula-
tions by flow cytometry. Although CCR5 was expressed at
high levels on intestinal intraepithelial lymphocytes
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(IELs), CXCR4 was expressed at very low levels on a
minority of IELs (mean fluorescence intensity = 9.97, stan-
dard deviation = 6, n = 7; Figure 2a). Despite the lack of
cell-surface expression, CXCR4 mRNA was readily
detected in these cells by reverse transcription (RT)-PCR
(Figure 2c), suggesting that surface expression of CXCR4
was downmodulated in vivo. It is known that CXCR4 is
rapidly internalized after SDF-1 binding and that CXCR4
relocates to the cell surface within minutes to hours after
ligand removal [11,12]. Thus, if SDF-1 downregulates
CXCR4 on intestinal lymphocytes in vivo, CXCR4 levels
would be expected to rise rapidly on removal of the ligand.
To test this possibility, freshly isolated IELs were cultured
at 37ºC in medium that lacked exogenous cytokines.
Importantly, within 1 hour of culture, CXCR4 levels were
clearly increased in the absence of exogenous SDF-1, and
by 4 hours of culture, CXCR4 levels had increased by
3.6-fold, from a maximum fluorescence intensity of 13
(SD = 6) on freshly isolated IELs to one of 45 (SD = 18,
n = 3, p < 0.05; Figure 2b) and remained high for at least
20 hours. In contrast, CXCR4 mRNA levels remained at
similar levels during this period, as assessed by semi-quan-
titative RT-PCR (Figure 2c). Furthermore, CCR5 levels
increased by less than twofold over the 24 hour period
(Figure 2b) and CXCR4 levels did not increase in the pres-
ence of exogenous SDF-1 (Figure 2b). Thus surface
CXCR4 expression was increased significantly on IELs in
the absence of increased CXCR4 mRNA expression.
Because lamina propria lymphocyte (LPL) isolation
required an extended incubation at 37ºC compared to
IELs, CXCR4 expression on LPLs was evaluated using a
modified isolation procedure in which the intestinal
mucosal fragments were incubated at 37ºC for only
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Figure 2
CXCR4 and CCR5 expression on IELs. (a) IELs were analyzed by flow
cytometry for the expression of chemokine receptors using the
monoclonal antibodies 2D7 (CCR5) and 12G5 (CXCR4). The black
line represents anti-chemokine-receptor staining and the blue line
indicates staining with an isotype-matched control antibody. IEL data
are from a representative experiment of seven performed.
(b) Expression of CXCR4 (squares) and CCR5 (circles) after culture
for the indicated times in RPMI 1640 media (Gibco BRL) containing
10% fetal calf serum, 50 µg/ml penicillin, 50 µg/ml streptomycin and
2 mM glutamine, alone (filled symbols) or with recombinant human
SDF-1 (200 ng/ml; R and D systems; open symbols). The percentage
increase in maximum fluorescence intensity (MFI) at time x was
determined according to the formula: (MFI of specific antibody — MFI
of control antibody)t=x / (MFI of specific antibody — MFI of control
antibody)t=0 × 100. Data represent the mean ± SD of three separate
experiments. (c) Expression of CXCR4 mRNA in IEL. CXCR4 mRNA
expression in freshly isolated IELs and IELs cultured for 4 h ex vivo
was determined by RT–PCR. The x-axis depicts a serial twofold
dilution of cDNA. The highest amount of cDNA used was 2 µl for the
G3PDH reaction and 1 µl for the CXCR4 reaction.
Figure 1
SDF-1 expression at mucosal surfaces. (a) A formalin-fixed paraffin-
embedded small intestinal tissue section stained with the K15C anti-
SDF-1 antibody or with a control antibody. Monoclonal antibody
staining is indicated by the red color. In situ hybridization was
performed using a 281 bp antisense and sense SDF-1 probe
comprising nucleotides 80–361 of the SDF-1β encoding gene
(GenBank accession number L36034 [24]) that detects both SDF-1α
and SDF-1β. Positive staining is indicated by the blue color. SM,
submucosa; C, crypt; V, villus. (b) SDF-1 expression in epithelial cells
of the rectum, vagina and cervix. Frozen tissue sections were
immunostained with the K15C anti-SDF-1 monoclonal antibody in the
presence or absence of SDF-1α. Dashed lines indicate the location of
the epithelial basement membrane, with epithelial cells above and
lamina propria shown below the line. The red color indicates
immunostaining. The scale bar represents 33 µm. Similar results were
obtained on sections taken from three separate small intestinal, vaginal
and cervical tissue samples and one rectal tissue sample.
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75 minutes, termed s-LPLs (see Supplementary mater-
ial). The shortened LPL isolation procedure resulted in a
greater IEL contamination, but because fewer IELs
(~5%) express CD4 compared with LPLs (~50%) [13], it
was possible to determine CXCR4 expression on CD4+
s-LPLs by gating on cells that express this marker. In this
analysis, CXCR4 levels were low on freshly isolated
CD4+ s-LPLs (Figure 3a, black line, clear profiles). Fur-
thermore, as with IELs, incubation of s-LPLs for 4 hours
at 37°C resulted in a greater than fourfold increase in
CXCR4 expression from 18.2 ± 14 to 102 ± 35 (Figure 3a,
shaded profiles, n = 3, p = 0.023; profiles from two experi-
ments are shown), whereas CCR5 profiles remained
unchanged (n = 2; Figure 3a). In addition, SDF-1α
induced CXCR4+ LPL chemotaxis (Figure 3b).
Together, these results show that intestinal lymphocytes
express high levels of the R5-HIV co-receptor CCR5 but
low levels of the X4-coreceptor. Furthermore, CXCR4
expression rapidly increased on both IELs and LPLs
during short-term culture. 
CXCR4 can be rapidly and transiently depleted from the
cell surface by treatment with phytohaemagglutinin,
phorbol myristate acetate or anti-CD3 antibodies [12,14–16]
or inflammatory cytokines, such as IFN-γ [17–19].
However, in our analysis, CCR5, which is also downmodu-
lated by anti-CD3 stimulation ([14] and our unpublished
observations), was not diminished in expression on IELs or
LPLs after isolation, indicating that T-cell receptor signal-
ing did not account for CXCR4 downmodulation. Further-
more, as CXCR4 mRNA was readily detected in IELs, the
lack of CXCR4 surface expression was not due to an
absence of CXCR4 transcription. In addition, the lack of an
apparent increase in CXCR4 mRNA expression in culture
suggests that increased surface expression results from a
relocation of receptor from intracellular stores. Taken
together, these results suggest that constitutive production
of SDF-1, rather than cytokines, induces CXCR4 down-
modulation on mucosal lymphocytes. 
Our findings have important implications for HIV propaga-
tion and transmission. CD4+ intestinal lymphocytes appear
to be a major site of SHIV replication during acute infec-
tion [6,20], leading to the proposal that the gut associated
CD4+ T lymphocytes are an important reservoir for the
propagation and subsequent dissemination of HIV parti-
cles [6,20]. SDF-1 mediated inhibition of CXCR4 cell
surface expression on intestinal lymphocytes would be pre-
dicted to markedly effect X4-HIV propagation within
these cells following infection via the systemic or mucosal
route. Indeed, Harouse and colleagues [6] have recently
demonstrated in a macaque infection model that inocula-
tion with R5-SHIV particles results in a rapid depletion of
intestinal CD4+ lymphocytes whereas inoculation with
X4-SHIV has no effect on this population. Similarly
mucosal SDF-1 expression would be predicted to reduce
X4-HIV transmission across mucosal sites. Mucosal trans-
mission from infected sexual partners is the major route by
which healthy people contract HIV-1. Thus, mucosal den-
dritic cells, macrophages and T lymphocytes are the first
infectable cells that are encountered by HIV virions.
Indeed, IELs and LPLs were recently shown to be the
first cells to be infected at sites of mucosal transmission
[21]. As in the intestine, prominent SDF-1 expression in
other epithelial sites would be predicted to downregulate
CXCR4 expression on these cells and reduce the chances
of X4-HIV infection. In support of this view, like intestinal
lymphocytes, freshly extracted epidermal Langerhans cells
express only low levels of CXCR4 [22] and rapid receptor
relocation occurs during short-term culture in vitro. Fur-
thermore, freshly isolated Langerhans cells are resistant to
infection by X4- but not R5-HIV-1 [22], and dendritic cells
that have emigrated from skin explants contain R5-HIV-1
but not X4-HIV-1 in an ex vivo HIV infection model [23].
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Figure 3
CXCR4 and CCR5 expression on CD4+ s-LPLs. (a) The expression of
CXCR4 and CCR5 on CD4+ s-LPLs was determined by flow
cytometry before (clear profile) or after (shaded profile) incubation in
media for 4 h at 37°C, as indicated. The blue line indicates staining
with the isotype-matched control antibody. Profiles from two out of
three experiments are shown for CXCR4 and one out of two
experiments for CCR5. (b) Chemotaxis of CXCR4+ LPLs in response
to SDF-1α. No chemokine (clear square), SDF-1α (filled squares), and
TARC (filled circles). Chemotaxis assays were performed using 24-well
Transwell plates (Corning Costar) as previously described [25], with
the exception that 5 × 105 cells were added to each well. Data are the
mean ± SD of duplicate wells and are from one representative
experiment of three performed. In this experiment, 100% migration was
equivalent to 12,296 cell counts.
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In conclusion, this is the first study to our knowledge that
demonstrates the constitutive expression of the CXCR4
ligand SDF-1 at mucosal surfaces. Our results suggest that
high levels of SDF-1 production at these sites may reduce
the transmission and propagation of X4-HIV at mucosal
sites and provides an explanation for the selectivity of
R5-HIV virus early in the infection process. 
Supplementary material
Supplementary material including a figure showing immunohistochemi-
cal staining with a control IgG2a antibody and additional methodological
details is available at http://current-biology.com/supmat/supmatin.htm.
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